China (Mainland)
Diamondsupplier 
Ertapenem sodium 153773-82-1 CAS NO.153773-82-1
- Min.Order: 1 Kilogram
- Payment Terms: L/C,T/T,Other
- Available Specifications:
- Product Details
Keywords
- 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylicacid,3-[[(3S,5S)-5-[[(3-carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-,monosodium salt, (4R,5S,6S)- (9CI)
- 153773-82-1
- Ertapenem sodium
Quick Details
- ProName: 1-Azabicyclo(3.2.0)hept-2-ene-2-carbox...
- CasNo: 153773-82-1
- Molecular Formula: C22H24N3NaO7S
- Appearance: White crystallization
- Application: in the treatment of severe atopic derm...
- DeliveryTime: in two weeks
- PackAge: 25kg/drum
- Port: SHANGHAI BEIJING
- ProductionCapacity: 10 Metric Ton/Day
- Purity: USP/EP/BP
- Storage: room temperature
- Transportation: AIR SEA TRAIN
- LimitNum: 1 Kilogram
Superiority
| Product Name: | Ertapenem sodium |
| Synonyms: | 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-(((3S,5S)-5-(((3-ca rboxyphenyl)amino)carbonyl)-3-pyrrolidinyl)thio)-6-((1R)-1-hydroxyethy l)-4-methyl-7-oxo-, monosodium salt, (4R,5S,6S)-;(4R,5S,6S)-3-[[(3S,5S)-5-[[(3-Carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium salt (1:1);ErtapeneM MonosodiuM;Invanz;L 749345;EtapeneM,Invanz,MK-0826,L-749,345;EtapeneM;ErtapeneM Crude |
| CAS: | 153773-82-1 |
| MF: | C22H26N3NaO7S |
| MW: | 499.51 |
| EINECS: | 1308068-626-2 |
| Product Categories: | API |
| Mol File: | 153773-82-1.mol |
Details
| Ertapenem sodium Usage And Synthesis |
| Uses | Ertapenem sodium has been used as a carbapenem in the NitroSpeed-Carba NP test in minimum inhibitory concentration (MIC) testing for differentiation of carbapenemases in Enterobacterales and Pseudomonas aeruginosa. It has also been used as an antibiotic to study its effects on the survival of septic mice. |
| Definition | ChEBI: The monosodium salt of ertapenem. It is used for the treatment of moderate to severe susceptible infections including intra-abdominal and acute gynaecological infections, pneumonia, and infections of the skin and of the urinary tract. It is more stable to renal dehydropeptidase I tham imipenem, and so unlike imipenem, its use with cilastatin, which inhibits the enzyme, is not required. |
